跳至主要内容
临床试验/NCT00730808
NCT00730808已完成不适用

Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (PreOP Booster) vs. Placebo in Surgical Patients (Pilot Study)

Fresenius Kabi1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Immunoinflammatory parameters

研究概览

简要总结

The aim of this pilot study is to investigate effectiveness, tolerability and safety of an oral nutritional supplement (PreOP Booster), given to rectal tumour patients prior to low anterior resection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • rectal tumour with indication for elective low anterior resection (open surgery, not laparoscopic surgery) or abdominoperineal resection (APR)
  • preoperative radiotherapy (5x5 Gy) or chemoradiation
  • loop ileostoma or colostoma;

排除标准

  • severe malnutrition
  • severe renal insufficiency
  • diabetes mellitus I or II
  • concomitant thyroid medication
  • corticosteroids
  • diuretic medication and antihypertensive medication
  • known or suspected allergy to any component of the investigational product(s)

结局指标

主要结局

Immunoinflammatory parameters

时间窗: on day -2, -1, 1, 2, 3, 5, and 7

Ischemia / reperfusion injury parameters

时间窗: on day -2, 1, 3, 5, and 7

Antioxidant / oxidant parameters

时间窗: on day -2, 1, 3, 5, and 7

次要结局

  • hand grip strength(on day -2, 1, 2, 3, 5, and 7)
  • Safety(on day -1, 0, 1, 2, 3, 5, and 7)
  • GI tolerance(on day -1, 0, 1, 2, and 7)
  • pre-and postoperative discomfort (well-being)(on day -1, and 0)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Effectiveness and Tolerability of an Oral... | 临床试验